APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enzyme-Linked Immunosorbent Assay (ELISA) Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Outlook and Growth Opportunities 2026

3 May 2026193 pages

Choose your research edition.

Industry ResearchEnzyme-Linked Immunosorbent Assay (ELISA) Service Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Analysis and Forecast 2026-2032222 pages · $4,950 USD

Market perspective

The global Enzyme-Linked Immunosorbent Assay (ELISA) Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Enzyme-Linked Immunosorbent Assay (ELISA) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Enzyme-Linked Immunosorbent Assay (ELISA) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enzyme-Linked Immunosorbent Assay (ELISA) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Enzyme-Linked Immunosorbent Assay (ELISA) Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Enzyme-Linked Immunosorbent Assay (ELISA) Service market include Virology Research Services Ltd, ACROBiosystems, Boster Bio, RayBiotech, Inc, Precision Medicine Group, LLC, Bio-Techne, Cellular Technology Limited（immunospot）, Sino Biological, Inc and R&D Systems, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Enzyme-Linked Immunosorbent Assay (ELISA) Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enzyme-Linked Immunosorbent Assay (ELISA) Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enzyme-Linked Immunosorbent Assay (ELISA) Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Enzyme-Linked Immunosorbent Assay (ELISA) Service market.

Enzyme-Linked Immunosorbent Assay (ELISA) Service Segment by Company

Virology Research Services Ltd

ACROBiosystems

Boster Bio

RayBiotech, Inc

Precision Medicine Group, LLC

Bio-Techne

Cellular Technology Limited（immunospot）

Sino Biological, Inc

R&D Systems, Inc

ProteoGenix

Eve Technologies

NorthEast BioAnalytical Laboratories LLC

mabtech

Pestka Biomedical Laboratories, Inc

Thermo Fisher Scientific

Antibodies Incorporated

Kaneka Eurogentec S.A

Enzyme-Linked Immunosorbent Assay (ELISA) Service Segment by Type

Routine ELISA Assays

Targeted Assay Development

Enzyme-Linked Immunosorbent Assay (ELISA) Service Segment by Application

Disease Diagnosis

Vaccine Effectiveness Evaluation

Drug Development

Allergen Testing

Others

Enzyme-Linked Immunosorbent Assay (ELISA) Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Enzyme-Linked Immunosorbent Assay (ELISA) Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Enzyme-Linked Immunosorbent Assay (ELISA) Service key companies, revenue, market share, and recent developments.

3. To split the Enzyme-Linked Immunosorbent Assay (ELISA) Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Enzyme-Linked Immunosorbent Assay (ELISA) Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Enzyme-Linked Immunosorbent Assay (ELISA) Service significant trends, drivers, influence factors in global and regions.

6. To analyze Enzyme-Linked Immunosorbent Assay (ELISA) Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzyme-Linked Immunosorbent Assay (ELISA) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzyme-Linked Immunosorbent Assay (ELISA) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzyme-Linked Immunosorbent Assay (ELISA) Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Enzyme-Linked Immunosorbent Assay (ELISA) Service industry.

Chapter 3: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Enzyme-Linked Immunosorbent Assay (ELISA) Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Enzyme-Linked Immunosorbent Assay (ELISA) Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Trends Table 2. Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Drivers Table 3. Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Opportunities and Challenges Table 4. Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Restraints Table 5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Company (2021-2026) Table 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Key Company Manufacturing Base & Headquarters Table 9. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Company, Product Type & Application Table 10. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Routine ELISA Assays Table 15. Significant Companies of Targeted Assay Development Table 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type (2021-2026) Table 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Disease Diagnosis Table 22. Significant Companies of Vaccine Effectiveness Evaluation Table 23. Significant Companies of Drug Development Table 24. Significant Companies of Allergen Testing Table 25. Significant Companies of Others Table 26. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application (2021-2026) Table 30. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application (2027-2032) Table 31. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Region (2021-2026) Table 34. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Region (2027-2032) Table 36. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Market Share by Country (2021-2026) Table 39. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Market Share by Country (2027-2032) Table 41. Virology Research Services Ltd Company Information Table 42. Virology Research Services Ltd Business Overview Table 43. Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 45. Virology Research Services Ltd Recent Development Table 46. ACROBiosystems Company Information Table 47. ACROBiosystems Business Overview Table 48. ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 50. ACROBiosystems Recent Development Table 51. Boster Bio Company Information Table 52. Boster Bio Business Overview Table 53. Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 55. Boster Bio Recent Development Table 56. RayBiotech, Inc Company Information Table 57. RayBiotech, Inc Business Overview Table 58. RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 60. RayBiotech, Inc Recent Development Table 61. Precision Medicine Group, LLC Company Information Table 62. Precision Medicine Group, LLC Business Overview Table 63. Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 65. Precision Medicine Group, LLC Recent Development Table 66. Bio-Techne Company Information Table 67. Bio-Techne Business Overview Table 68. Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 70. Bio-Techne Recent Development Table 71. Cellular Technology Limited（immunospot） Company Information Table 72. Cellular Technology Limited（immunospot） Business Overview Table 73. Cellular Technology Limited（immunospot） Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Cellular Technology Limited（immunospot） Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 75. Cellular Technology Limited（immunospot） Recent Development Table 76. Sino Biological, Inc Company Information Table 77. Sino Biological, Inc Business Overview Table 78. Sino Biological, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Sino Biological, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 80. Sino Biological, Inc Recent Development Table 81. R&D Systems, Inc Company Information Table 82. R&D Systems, Inc Business Overview Table 83. R&D Systems, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. R&D Systems, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 85. R&D Systems, Inc Recent Development Table 86. ProteoGenix Company Information Table 87. ProteoGenix Business Overview Table 88. ProteoGenix Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. ProteoGenix Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 90. ProteoGenix Recent Development Table 91. Eve Technologies Company Information Table 92. Eve Technologies Business Overview Table 93. Eve Technologies Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Eve Technologies Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 95. Eve Technologies Recent Development Table 96. NorthEast BioAnalytical Laboratories LLC Company Information Table 97. NorthEast BioAnalytical Laboratories LLC Business Overview Table 98. NorthEast BioAnalytical Laboratories LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. NorthEast BioAnalytical Laboratories LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 100. NorthEast BioAnalytical Laboratories LLC Recent Development Table 101. mabtech Company Information Table 102. mabtech Business Overview Table 103. mabtech Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. mabtech Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 105. mabtech Recent Development Table 106. Pestka Biomedical Laboratories, Inc Company Information Table 107. Pestka Biomedical Laboratories, Inc Business Overview Table 108. Pestka Biomedical Laboratories, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Pestka Biomedical Laboratories, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 110. Pestka Biomedical Laboratories, Inc Recent Development Table 111. Thermo Fisher Scientific Company Information Table 112. Thermo Fisher Scientific Business Overview Table 113. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 115. Thermo Fisher Scientific Recent Development Table 116. Antibodies Incorporated Company Information Table 117. Antibodies Incorporated Business Overview Table 118. Antibodies Incorporated Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Antibodies Incorporated Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 120. Antibodies Incorporated Recent Development Table 121. Kaneka Eurogentec S.A Company Information Table 122. Kaneka Eurogentec S.A Business Overview Table 123. Kaneka Eurogentec S.A Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Kaneka Eurogentec S.A Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 125. Kaneka Eurogentec S.A Recent Development Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Image Figure 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Routine ELISA Assays Image Figure 8. Targeted Assay Development Image Figure 9. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type (2021-2032) Figure 12. Disease Diagnosis Image Figure 13. Vaccine Effectiveness Evaluation Image Figure 14. Drug Development Image Figure 15. Allergen Testing Image Figure 16. Others Image Figure 17. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application (2021-2032) Figure 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Routine ELISA Assays
  • Targeted Assay Development
Applications
  • Disease Diagnosis
  • Vaccine Effectiveness Evaluation
  • Drug Development
  • Allergen Testing
  • Others
Companies covered
  • Virology Research Services Ltd
  • ACROBiosystems
  • Boster Bio
  • RayBiotech, Inc
  • Precision Medicine Group, LLC
  • Bio-Techne
  • Cellular Technology Limited（immunospot）
  • Sino Biological, Inc
  • R&D Systems, Inc
  • ProteoGenix
  • Eve Technologies
  • NorthEast BioAnalytical Laboratories LLC
  • mabtech
  • Pestka Biomedical Laboratories, Inc
  • Thermo Fisher Scientific
  • Antibodies Incorporated
  • Kaneka Eurogentec S.A

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Dynamics
  1. 2.1 Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Trends
  2. 2.2 Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Drivers
  3. 2.3 Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Opportunities and Challenges
  4. 2.4 Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Restraints
3 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market by Company
  1. 3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Company Revenue Ranking in 2025
  2. 3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Company (2021-2026)
  3. 3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Company Ranking (2024-2026)
  4. 3.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Company Product Type and Application
  6. 3.6 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Enzyme-Linked Immunosorbent Assay (ELISA) Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market by Type
  1. 4.1 Enzyme-Linked Immunosorbent Assay (ELISA) Service Type Introduction
  2. 4.1.1 Routine ELISA Assays
  3. 4.1.2 Targeted Assay Development
  4. 4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Type
  5. 4.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type (2021-2032)
5 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market by Application
  1. 5.1 Enzyme-Linked Immunosorbent Assay (ELISA) Service Application Introduction
  2. 5.1.1 Disease Diagnosis
  3. 5.1.2 Vaccine Effectiveness Evaluation
  4. 5.1.3 Drug Development
  5. 5.1.4 Allergen Testing
  6. 5.1.5 Others
  7. 5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Application
  8. 5.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application (2021-2032)
6 Enzyme-Linked Immunosorbent Assay (ELISA) Service Regional Value Analysis
  1. 6.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value (2021-2032)
  7. 6.3.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value (2021-2032)
  10. 6.4.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value (2021-2032)
  16. 6.6.2 South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Country, 2025 VS 2032
7 Enzyme-Linked Immunosorbent Assay (ELISA) Service Country-level Value Analysis
  1. 7.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Virology Research Services Ltd
  2. 8.1.1 Virology Research Services Ltd Company Information
  3. 8.1.2 Virology Research Services Ltd Business Overview
  4. 8.1.3 Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  6. 8.1.5 Virology Research Services Ltd Recent Developments
  7. 8.2 ACROBiosystems
  8. 8.2.1 ACROBiosystems Company Information
  9. 8.2.2 ACROBiosystems Business Overview
  10. 8.2.3 ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  12. 8.2.5 ACROBiosystems Recent Developments
  13. 8.3 Boster Bio
  14. 8.3.1 Boster Bio Company Information
  15. 8.3.2 Boster Bio Business Overview
  16. 8.3.3 Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  18. 8.3.5 Boster Bio Recent Developments
  19. 8.4 RayBiotech, Inc
  20. 8.4.1 RayBiotech, Inc Company Information
  21. 8.4.2 RayBiotech, Inc Business Overview
  22. 8.4.3 RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  24. 8.4.5 RayBiotech, Inc Recent Developments
  25. 8.5 Precision Medicine Group, LLC
  26. 8.5.1 Precision Medicine Group, LLC Company Information
  27. 8.5.2 Precision Medicine Group, LLC Business Overview
  28. 8.5.3 Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  30. 8.5.5 Precision Medicine Group, LLC Recent Developments
  31. 8.6 Bio-Techne
  32. 8.6.1 Bio-Techne Company Information
  33. 8.6.2 Bio-Techne Business Overview
  34. 8.6.3 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  36. 8.6.5 Bio-Techne Recent Developments
  37. 8.7 Cellular Technology Limited（immunospot）
  38. 8.7.1 Cellular Technology Limited（immunospot） Company Information
  39. 8.7.2 Cellular Technology Limited（immunospot） Business Overview
  40. 8.7.3 Cellular Technology Limited（immunospot） Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cellular Technology Limited（immunospot） Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  42. 8.7.5 Cellular Technology Limited（immunospot） Recent Developments
  43. 8.8 Sino Biological, Inc
  44. 8.8.1 Sino Biological, Inc Company Information
  45. 8.8.2 Sino Biological, Inc Business Overview
  46. 8.8.3 Sino Biological, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sino Biological, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  48. 8.8.5 Sino Biological, Inc Recent Developments
  49. 8.9 R&D Systems, Inc
  50. 8.9.1 R&D Systems, Inc Company Information
  51. 8.9.2 R&D Systems, Inc Business Overview
  52. 8.9.3 R&D Systems, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 R&D Systems, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  54. 8.9.5 R&D Systems, Inc Recent Developments
  55. 8.10 ProteoGenix
  56. 8.10.1 ProteoGenix Company Information
  57. 8.10.2 ProteoGenix Business Overview
  58. 8.10.3 ProteoGenix Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ProteoGenix Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  60. 8.10.5 ProteoGenix Recent Developments
  61. 8.11 Eve Technologies
  62. 8.11.1 Eve Technologies Company Information
  63. 8.11.2 Eve Technologies Business Overview
  64. 8.11.3 Eve Technologies Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Eve Technologies Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  66. 8.11.5 Eve Technologies Recent Developments
  67. 8.12 NorthEast BioAnalytical Laboratories LLC
  68. 8.12.1 NorthEast BioAnalytical Laboratories LLC Company Information
  69. 8.12.2 NorthEast BioAnalytical Laboratories LLC Business Overview
  70. 8.12.3 NorthEast BioAnalytical Laboratories LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 NorthEast BioAnalytical Laboratories LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  72. 8.12.5 NorthEast BioAnalytical Laboratories LLC Recent Developments
  73. 8.13 mabtech
  74. 8.13.1 mabtech Company Information
  75. 8.13.2 mabtech Business Overview
  76. 8.13.3 mabtech Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 mabtech Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  78. 8.13.5 mabtech Recent Developments
  79. 8.14 Pestka Biomedical Laboratories, Inc
  80. 8.14.1 Pestka Biomedical Laboratories, Inc Company Information
  81. 8.14.2 Pestka Biomedical Laboratories, Inc Business Overview
  82. 8.14.3 Pestka Biomedical Laboratories, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Pestka Biomedical Laboratories, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  84. 8.14.5 Pestka Biomedical Laboratories, Inc Recent Developments
  85. 8.15 Thermo Fisher Scientific
  86. 8.15.1 Thermo Fisher Scientific Company Information
  87. 8.15.2 Thermo Fisher Scientific Business Overview
  88. 8.15.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  90. 8.15.5 Thermo Fisher Scientific Recent Developments
  91. 8.16 Antibodies Incorporated
  92. 8.16.1 Antibodies Incorporated Company Information
  93. 8.16.2 Antibodies Incorporated Business Overview
  94. 8.16.3 Antibodies Incorporated Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Antibodies Incorporated Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  96. 8.16.5 Antibodies Incorporated Recent Developments
  97. 8.17 Kaneka Eurogentec S.A
  98. 8.17.1 Kaneka Eurogentec S.A Company Information
  99. 8.17.2 Kaneka Eurogentec S.A Business Overview
  100. 8.17.3 Kaneka Eurogentec S.A Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Kaneka Eurogentec S.A Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  102. 8.17.5 Kaneka Eurogentec S.A Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst